Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06575218

The Effectiveness of Virtual Reality Training Program

Alzheimer's disease is the most common type of dementia, accounting for 50% of all cases. Advanced age is a significant risk factor for AD. Virtual Reality (VR) is an interactive video game technology that provides computer-generated environments that include physical activity and provide users with experiences similar to those in the real world. VR technology can be used for rehabilitation purposes in individuals with various orthopedic and neurological disorders due to its ability to enhance motor, cognitive learning and neural plasticity (1,2). The aim of our study was to examine the effect of the Virtual Reality Training Program on cognition in individuals with Alzheimer's disease living in the community.

Recruiting

Interested in participating?

Request Info

Key information

Age range

55 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ebru Akbuğa Koç

Istanbul, Turkey (Türkiye)

Location status: Recruiting

Location contact

Ebru Akbuğa Koç

CONTACT

[email protected]

05548611344

Ebru Akbuğa Koç

PRINCIPAL_INVESTIGATOR

About this study

The aim of our study was to examine the effect of the Virtual Reality Training Program on cognition in individuals with Alzheimer's disease living in the community. Prospective Randomized Controlled Single Blind Study After the patients and their relatives are informed in detail before the study, they will be asked whether they want to participate in the study and the individuals or relatives of the patients who approve of participating in the study will be asked to sign the informed consent form. Individuals who meet the inclusion criteria will be randomly divided into three groups by a single researcher: Virtual reality training program, cognitive exercise with traditional balance exercises, and traditional balance exercises only.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥ 55 years and older Diagnosed with AD according to DSM-IV diagnostic criteria by a neurologist, MOCA ≥ 16 Clinical Dementia Rating Scale < 2

Exclusion criteria

  • Various mobility restrictions, musculoskeletal disorders, (wheelchair use, etc.) Clinically significant aphasia (must be able to understand the therapist's commands) Significant visual or sensory impairment

Treatment and study plan

Virtual reality training

Device

Virtual reality training

Conventional exercise and cognitive exercise

Other

Conventional exercise and cognitive exercise

Control

Other

no intervention

Primary outcomes

  1. Montreal cognitive assessment scale

    Time frame: 12 weeks

    MOCA is a short cognitive assessment method developed to detect particularly mild stages of cognitive impairment.

  2. Berg Balance Scale

    Time frame: 12 weeks

    BBS measures static and dynamic balance in elderly individuals

  3. Time up and Go Test

    Time frame: 12 weeks

    TUG test evaluates fall risk, mobility and physical performance in the elderly

Study contacts

Contact information is provided by the study sponsor or research team.

Ebru Akbuga Koc

CONTACT

[email protected]

216

Sponsors and collaborators

Lead sponsor

Yeditepe University

Other

Registry information

Official study title

The Effectiveness of Virtual Reality Training Program in Community Dwelling Older Adults With Alzheimer's Disease

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Aug 28, 2024
Registry last updated
Aug 30, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.